Canada becomes first country to approve experimental ALS drug treatment Albrioza – National |…
Health Canada has approved an experimental drug for amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease, as uncertainty persists about the drug’s clinical benefit.
Amylyx Pharmaceuticals said in a press release…